{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T16:49:56Z","timestamp":1789145396281,"version":"build-2803163510"},"reference-count":26,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["RMHP"],"DOI":"10.2147\/rmhp.s475048","type":"journal-article","created":{"date-parts":[[2024,11,16]],"date-time":"2024-11-16T10:10:12Z","timestamp":1731751812000},"page":"2829-2837","source":"Crossref","is-referenced-by-count":1,"title":["Economic Evaluation of Adding Daratumumab to Carfilzomib and Dexamethasone for Relapsed or Refractory Multiple Myeloma"],"prefix":"10.2147","volume":"Volume 17","author":[{"given":"Lidan","family":"Yi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8739-6236","authenticated-orcid":true,"given":"Qiao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chongqing","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaomin","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinbo","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiying","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6050-4137","authenticated-orcid":true,"given":"Xiaohui","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2024,11]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1186\/s13045-019-0807-5","volume":"12","author":"Liu","year":"2019","journal-title":"J Hematol Oncol"},{"key":"ref2","first-page":"373","volume":"95","author":"Michels","year":"2017","journal-title":"Am Fam Physician"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/S1470-2045(21)00579-9","volume":"23","author":"Usmani","year":"2022","journal-title":"Lancet Oncol"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"3739","DOI":"10.1182\/bloodadvances.2023010026","volume":"7","author":"Usmani","year":"2023","journal-title":"Blood Adv"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.clinthera.2019.12.007","volume":"42","author":"Zeng","year":"2020","journal-title":"Clin Ther"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1016\/j.clinthera.2018.05.012","volume":"40","author":"Zhang","year":"2018","journal-title":"Clin Ther"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"29","DOI":"10.18553\/jmcp.2018.24.1.29","volume":"24","author":"Carlson","year":"2018","journal-title":"J Manag Care Spec Pharm"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"1986","DOI":"10.1016\/j.clinthera.2017.08.010","volume":"39","author":"Pelligra","year":"2017","journal-title":"Clin Ther"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"E68","DOI":"10.1002\/ajh.25372","volume":"94","author":"Gong","year":"2019","journal-title":"Am J Hematol"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1080\/14737167.2022.2017285","volume":"22","author":"Wong","year":"2022","journal-title":"Expert Rev Pharmacoecon Outcomes Res"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s12962-024-00525-4","volume":"22","author":"Goudarzi","year":"2024","journal-title":"Cost Eff Res Alloc"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"2379","DOI":"10.1007\/s12325-021-01699-6","volume":"38","author":"Zeng","year":"2021","journal-title":"Adv Ther"},{"key":"ref13","unstructured":"Chinese Pharmaceutical Association. China Guidelines for Pharmacoeconomic Evaluations; 2020. Available from: https:\/\/www.cpa.org.cn\/cpadmn\/attached\/file\/20201203\/1606977380634185.pdf. Accessed April 10, 2024."},{"key":"ref14","unstructured":"The People\u2019s Bank of China. Exchange rate. Available from: http:\/\/www.pbc.gov.cn. Accessed April 10, 2024."},{"key":"ref15","unstructured":"National Bureau of Statistics of China. Available from: http:\/\/www.stats.gov.cn\/. Accessed April 10, 2024."},{"key":"ref16","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.jval.2021.11.1351","volume":"25","author":"Husereau","year":"2022","journal-title":"Value in Health"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/1471-2288-12-9","volume":"12","author":"Guyot","year":"2012","journal-title":"BMC Med Res Method"},{"key":"ref18","unstructured":"World Health Organization. Global health observatory data repository: life tables by country China. Available from: https:\/\/apps.who.int\/gho\/data\/view.main.60340. Accessed December 10, 2023."},{"key":"ref19","unstructured":"Chongqing Kangzhou Big Data (Group) Co., LTD. The big data service platform for China\u2019s health industry. Available from: https:\/\/www.yaozh.com\/. Accessed November 16, 2023."},{"key":"ref20","doi-asserted-by":"publisher","first-page":"e0232240","DOI":"10.1371\/journal.pone.0232240","volume":"15","author":"Li","year":"2020","journal-title":"PLoS One"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1080\/17474086.2017.1391088","volume":"10","author":"Jakubowiak","year":"2017","journal-title":"Expert Rev Hematol"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1080\/03007995.2016.1232704","volume":"33","author":"Lloyd","year":"2017","journal-title":"Curr Med Res Opin"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1080\/13696998.2016.1194278","volume":"19","author":"Jakubowiak","year":"2016","journal-title":"J Med Econ"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"e0199553","DOI":"10.1371\/journal.pone.0199553","volume":"13","author":"Peng","year":"2018","journal-title":"PLoS One"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"942800","DOI":"10.3389\/fpubh.2022.942800","volume":"10","author":"Yan","year":"2022","journal-title":"Front Public Health"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/j.clinthera.2019.01.009","volume":"41","author":"Ailawadhi","year":"2019","journal-title":"Clin Ther"}],"container-title":["Risk Management and Healthcare Policy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dovepress.com\/article\/download\/97362","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.dovepress.com\/article\/download\/97362","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,16]],"date-time":"2024-11-16T10:10:16Z","timestamp":1731751816000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.dovepress.com\/economic-evaluation-of-adding-daratumumab-to-carfilzomib-and-dexametha-peer-reviewed-fulltext-article-RMHP"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":26,"URL":"https:\/\/doi.org\/10.2147\/rmhp.s475048","relation":{},"ISSN":["1179-1594"],"issn-type":[{"value":"1179-1594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11]]}}}